CX CANCERVAX

Live / Registered — Registered (as of 18 Jun 2024)

What this means for you

Registered since 18 Jun 2024. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
97777928
Registration number
7417641
Mark type
Design + words
Filed
02 Feb 2023
Published for opposition
02 Apr 2024
Registered
18 Jun 2024
Attorney of record
Jeffery M. Lillywhite

Goods and services

  • Class 042 — Scientific and technological services: Pharmaceutical drug development services; Pharmaceutical research services; Providing information about medical research in the field of cancer, pharmaceutical drugs, cancer risks, and Immunotherapy

Owner

Prosecution history

  • 18 Jun 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 18 Jun 2024 — REGISTERED-PRINCIPAL REGISTER
  • 13 Jun 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
  • 13 Jun 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
  • 13 Jun 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
  • 02 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 02 Apr 2024 — PUBLISHED FOR OPPOSITION
  • 13 Mar 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 26 Feb 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 07 Feb 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
  • 06 Feb 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
  • 06 Feb 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
  • 13 Nov 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
  • 13 Nov 2023 — NON-FINAL ACTION E-MAILED
  • 13 Nov 2023 — NON-FINAL ACTION WRITTEN

View this trademark record on Marksy